- 01A vitamin dose and a drug dose are different things
Adults need 14 to 16 mg of niacin a day, which food covers; lipid treatment uses 1,000 to 2,000 mg, roughly 60 to 140 times more, and brings the liver, blood-sugar and uric-acid effects of a drug.
- 02Niacin moves HDL and triglycerides, not heart attacks on top of a statin
In AIM-HIGH, HDL rose from 35 to 42 mg/dL and triglycerides fell from 164 to 122 mg/dL, yet events were 16.4 percent on niacin and 16.2 percent on placebo; HPS2-THRIVE in 25,673 people found no benefit either, with more diabetes, infection and bleeding.
- 03Only nicotinic acid lowers cholesterol
Niacinamide has no lipid-lowering activity, and tested no-flush (inositol hexanicotinate) products contained no free nicotinic acid, so neither can stand in for prescription niacin.
The same word on a supplement bottle and a prescription covers two different amounts. A B-complex might hold 15 mg of niacin; prescription extended-release niacin is taken at 1,000 to 2,000 mg a night for cholesterol 2. The first is a vitamin dose. The second is a drug dose, about 60 to 125 times a man's daily requirement, with drug-level side effects and a blood-test schedule to match.
Niacin, niacinamide, no-flush niacin and NR: which is which
Vitamin B3 is a family of molecules. Nicotinic acid is the one called niacin on a prescription, and the only one that changes cholesterol. Niacinamide, also called nicotinamide, does the vitamin job without flushing, and the US prescribing information for niacin states that it has no lipid-lowering activity 2. No-flush niacin is usually inositol hexanicotinate, nicotinic acid bound to a sugar alcohol; when researchers measured 500 mg products bought from pharmacies, health food stores and online sellers, the no-flush ones contained no free nicotinic acid at all 6.
| Form | Flushes? | Changes cholesterol? | Main use |
|---|---|---|---|
| Nicotinic acid, immediate-release (crystalline) | Yes, strongly | Yes | Vitamin, and the oldest lipid form |
| Nicotinic acid, prescription extended-release | Yes, less often | Yes | Prescription lipid treatment 2 |
| Nicotinic acid, over-the-counter sustained-release | Less | Yes | Sold as a supplement; the highest liver risk 5 |
| Niacinamide (nicotinamide) | No | No 2 | Multivitamins; studied in people with past skin cancers 9 |
| Inositol hexanicotinate (no-flush) | No | Not reliably; tested products held no free nicotinic acid 6 | Marketed as flush-free niacin |
| Nicotinamide riboside (NR) | No | Not used for cholesterol | Marketed to raise NAD+ |
The three nicotinic acid forms are not interchangeable at the same dose. The prescription label warns against swapping its extended-release tablets for sustained-release or immediate-release niacin 2, because release speed changes both the flush and the liver risk.
How much niacin you need, and where it comes from
Adult men need 16 mg of niacin equivalents a day and adult women 14 mg, rising to 18 mg in pregnancy and 17 mg while breastfeeding 1. Niacin equivalents count the body's own production too: the liver makes about 1 mg of niacin from every 60 mg of tryptophan, an amino acid in protein 1. A 3-ounce roasted chicken breast has about 10 mg of niacin, the same amount of salmon or canned light tuna about 8.6 mg, and an ounce of dry-roasted peanuts about 4 mg; many US breads and cereals are fortified as well 1.
The adult upper limit for niacin is 35 mg a day from supplements and fortified foods, set to avoid flushing 1. That limit does not apply to niacin in ordinary food or to treatment a prescriber supervises. Niacin deficiency, called pellagra, causes a rash on sun-exposed skin, diarrhea and confusion; in the US it is rare and mostly seen with heavy alcohol use, undernutrition, carcinoid syndrome or long-term use of isoniazid, a tuberculosis drug 1.
Vitamin B3 in other products
What niacin does to cholesterol
At lipid doses, nicotinic acid moves triglycerides and HDL more than LDL, and the change grows with the dose. The label's pooled placebo-controlled studies found the median changes below, with larger changes in women than in men 2. Niacin also lowers lipoprotein(a), the inherited particle most cholesterol drugs leave alone: in AIM-HIGH it fell by 21 percent at one year, yet Lp(a) still predicted heart events in both groups and niacin did not reduce them 12.
| Extended-release niacin, nightly | LDL | HDL | Triglycerides |
|---|---|---|---|
| 1,000 mg | Down 7% | Up 14% | Down 16% 2 |
| 1,500 mg | Down 13% | Up 19% | Down 25% 2 |
| 2,000 mg | Down 16% | Up 22% | Down 38% 2 |
AIM-HIGH, which gave 3,414 people with heart disease on simvastatin either extended-release niacin or placebo, shows the same pattern in mg/dL 3.
| Marker in AIM-HIGH (niacin group) | At the start | After 2 years |
|---|---|---|
| HDL cholesterol | 35 mg/dL (0.91 mmol/L) | 42 mg/dL (1.08 mmol/L) 3 |
| Triglycerides | 164 mg/dL (1.85 mmol/L) | 122 mg/dL (1.38 mmol/L) 3 |
| LDL cholesterol | 74 mg/dL (1.91 mmol/L) | 62 mg/dL (1.60 mmol/L) 3 |
Markers niacin moves
LDL causes plaque, so lowering LDL lowers heart attacks and strokes. Low HDL travels with risk, but pushing HDL up has not lowered it.
If you have a panel from before and after niacin, run both through the ratios below. The triglyceride-to-HDL ratio and non-HDL cholesterol are where niacin shows up most.
Your cholesterol ratios, in context
Two ratios that say more than any single number. Nothing leaves your browser.

Does niacin prevent heart attacks?
Not when it is added to a statin: the two large trials that tested that found no benefit. Before statins, the Coronary Drug Project, completed in 1975 in men who had already had a heart attack, found fewer repeat heart attacks on niacin, 8.9 percent within 5 years against 12.2 percent on placebo. Deaths were similar at 5 years. At 15 years, long after the drug had stopped, mortality was 52.0 against 58.2 percent, a result the trial was not designed to test 2.
| Trial | Who took part | What was compared | Result |
|---|---|---|---|
| Coronary Drug Project (completed 1975) | Men 30 to 64 after a heart attack, before statins | Nicotinic acid vs placebo | Fewer repeat nonfatal heart attacks; no 5-year survival difference; 15-year mortality 52.0% vs 58.2%, not a planned endpoint 2 |
| AIM-HIGH (2011) | 3,414 people with heart disease on simvastatin | Extended-release niacin vs placebo | Stopped early; events 16.4% vs 16.2% 3 |
| HPS2-THRIVE (2014) | 25,673 adults with vascular disease on statin-based treatment | Extended-release niacin with laropiprant (a drug added to reduce the flush) vs placebo | Events 13.2% vs 13.7%, not significant; more serious harms 4 |
For every 100 people on niacin with laropiprant rather than placebo in HPS2-THRIVE, about 4 more of those with diabetes had serious problems with diabetes control, about 1 more of those without diabetes was newly diagnosed with it, 1 to 2 more had a serious infection and nearly 1 more had serious bleeding 4. If your glucose or HbA1c creeps up on niacin, prediabetes explains what the numbers mean.
In April 2016 the FDA withdrew approval of the indications for taking extended-release niacin together with a statin 11, and the current US label states the result directly.
Niacin extended-release has not been shown to reduce cardiovascular morbidity or mortality among patients already treated with a statin.Niacin extended-release tablets, US prescribing information, section 5.1 2
The total is the least useful number: what drives risk is LDL, and apoB (a count of the particles that carry it), read against your overall heart risk.
For lowering LDL and ApoB, guidelines put statins such as rosuvastatin first, with ezetimibe, a pill that blocks cholesterol absorption in the gut, as the usual add-on. Which fits is the clinician's call, and high cholesterol covers that path. Niacin is still labeled for a few uses, including severe high triglycerides that carry a risk of pancreatitis when diet has not brought them down 2, and that is a specialist decision.
Why niacin makes you flush, and how to make it milder
The flush starts when nicotinic acid binds a receptor on immune cells in the skin. In preclinical work, removing that receptor stopped nicotinic acid from causing a flush, and blocking prostaglandin production reduced it 7. The flush is harmless, but it is a common reason people stop the drug 7.
How a dose of niacin becomes a flush
The label lists what makes the flush milder, shown in the box below: start low, raise the dose slowly and never take it on an empty stomach. Aspirin taken 30 minutes before can also reduce flushing 2, but aspirin carries its own bleeding risk, so that choice belongs to the prescriber. Extended-release flushes less often: at 1,500 mg a day, people averaged 1.9 flushing episodes over 4 weeks against 8.6 on immediate-release 2.
How prescription extended-release niacin is taken
Side effects and the blood tests to watch
The liver is the main worry with lipid-dose niacin, and the form matters most. In a 1994 randomized trial that raised doses step by step, 12 of 23 people on sustained-release niacin (52 percent) developed liver toxicity, against none of 23 on immediate-release; the authors concluded that "the SR form of niacin is hepatotoxic and should be restricted from use" 5.
Niacin also raises blood sugar, raises uric acid (which can set off gout), and slightly lowers platelets and phosphorus: at 2,000 mg, platelets fell by about 11 percent and phosphorus by 13 percent on average 2. The label lists active liver disease, unexplained raised liver enzymes, an active peptic ulcer and arterial bleeding as reasons not to take niacin. It also advises that niacin be stopped in pregnancy when it is used for cholesterol, a change to make with the prescriber 2.
| Test | Why it is checked | When the label suggests it |
|---|---|---|
| ALT and AST, two liver enzymes | To catch liver injury early | Before starting, every 6 to 12 weeks in the first year, then about every 6 months 2 |
| Fasting glucose or HbA1c | Niacin raises blood sugar; HPS2-THRIVE found more new diabetes 4 | Closely in the first months for anyone with, or at risk of, diabetes 2 |
| Uric acid | Levels rise and gout can flare | No set schedule; the label advises caution in anyone prone to gout 2 |
| Creatine kinase (CK) | Muscle injury is more likely with a statin | If muscle pain, tenderness or weakness appears 2 |
| Platelets and prothrombin time | Small fall in platelets, small rise in clotting time | Closely in anyone on a blood thinner 2 |
| Lipid panel | Shows your own response | After each change, as the prescriber plans |
If ALT or AST keeps rising between checks, especially to 3 times the top of the normal range and staying there, or rises along with nausea, fever or feeling unwell, the label says niacin should be stopped; bring both results to the prescriber 2. Liver enzymes explained covers how to read the rise, and the AST to ALT ratio calculator puts the two side by side.
Tell the prescriber about statins, which raise the risk of muscle injury, and about blood-pressure drugs and nitrates, which together with niacin can cause dizziness and low blood pressure. Bile-acid binders such as cholestyramine bind niacin, so doses are spaced 4 to 6 hours apart. Also mention blood thinners, heavy alcohol use and any other supplement that contains niacin or niacinamide 2. On a blood thinner, clotting tests explained covers the prothrombin time.
Safety markers on lipid-dose niacin
Can you get too much niacin from food?
Possibly, though the evidence is early. A 2024 Nature Medicine study measured 2PY and 4PY, the breakdown products of excess niacin, in about 4,300 people in US and European cohorts. Higher levels went with a 1.6 to 2.0 times higher 3-year risk of heart attack, stroke or death after adjustment, and in preclinical work 4PY switched on VCAM-1, a molecule that makes vessel walls catch white cells 8. An association like this cannot prove that dietary niacin causes heart disease, and it gives no reason to cut niacin-rich foods. It adds one more reason to leave high-dose niacin to a prescriber.
Niacin will not help you pass a drug test
Niacin does not hide drugs in urine, and no data support using it for that 10. People who tried have ended up in emergency departments. One previously healthy 23-year-old man took about 22.5 grams of sustained-release niacin over 48 hours before a pre-employment screen. He arrived confused and feverish, with kidney failure, broken-down red cells, a low platelet count and failing blood clotting, and needed a ventilator and dialysis before he recovered 10.
Niacin, NAD+ and anti-aging claims
Every form of vitamin B3 can feed NAD+, a molecule cells use to make energy and repair DNA, which is why nicotinamide riboside and NMN are sold for healthy aging. In a 6-week trial in healthy middle-aged and older adults, NR raised NAD+ in blood cells and was well tolerated 13. No B3 form has been shown to extend human life, and NR is not a cholesterol treatment. Compared with niacinamide, it reaches the same molecule but has fewer long-term human trials.
Niacinamide has one strong human trial of its own. In ONTRAC, 386 people with at least two recent non-melanoma skin cancers took niacinamide or placebo for 12 months; new skin cancers were 23 percent lower on niacinamide, and the benefit faded after stopping 9. That result applies to people with a history of skin cancer, and whether to take niacinamide for it is a decision for their dermatologist.
Should you take niacin?
As a vitamin, most people already get enough niacin from food, and a standard multivitamin or B-complex covers the rest 1. For cholesterol, lipid-dose niacin belongs with a prescriber, as prescription extended-release or monitored immediate-release niacin and never over-the-counter sustained-release 5, with liver tests before the first dose and blood sugar watched closely 2. If you came here because your HDL is low or your triglycerides are high, cholesterol vs triglycerides and foods that lower cholesterol cover the first steps to raise with your clinician.
If you take niacin now, keep the follow-up tests your prescriber orders and read them side by side; how to read your lipid panel walks through each line.
Free, no accountRead your blood testHolding a lipid panel and liver tests from before and after niacin? Read every line of both, free.Read my results
Citations
- NIH Office of Dietary Supplements. Niacin: Fact Sheet for Health Professionals
- Niacin extended-release tablets, US prescribing information (Amneal Pharmaceuticals), October 2025. DailyMed, US National Library of Medicine
- AIM-HIGH Investigators. Niacin in patients with low HDL cholesterol levels receiving intensive statin therapy. New England Journal of Medicine, 2011;365:2255-2267
- HPS2-THRIVE Collaborative Group. Effects of extended-release niacin with laropiprant in high-risk patients. New England Journal of Medicine, 2014;371:203-212
- McKenney JM et al. A comparison of the efficacy and toxic effects of sustained- vs immediate-release niacin in hypercholesterolemic patients. JAMA, 1994;271(9):672-677
- Meyers CD et al. Varying cost and free nicotinic acid content in over-the-counter niacin preparations for dyslipidemia. Annals of Internal Medicine, 2003;139(12):996-1002
- Benyo Z et al. GPR109A (PUMA-G/HM74A) mediates nicotinic acid-induced flushing. Journal of Clinical Investigation, 2005;115(12):3634-3640
- Ferrell M et al. A terminal metabolite of niacin promotes vascular inflammation and contributes to cardiovascular disease risk. Nature Medicine, 2024;30:424-434
- Chen AC et al. A phase 3 randomized trial of nicotinamide for skin-cancer chemoprevention (ONTRAC). New England Journal of Medicine, 2015;373:1618-1626
- Daul AM, Beuhler MC. Niacin toxicity resulting from urine drug test evasion. Journal of Emergency Medicine, 2011;41(3):e65-e68
- US Food and Drug Administration. AbbVie Inc. et al.; Withdrawal of approval of indications related to the coadministration with statins in applications for niacin extended-release tablets and fenofibric acid delayed-release capsules. Federal Register, 18 April 2016
- Albers JJ et al. Relationship of apolipoproteins A-1 and B, and lipoprotein(a) to cardiovascular outcomes: the AIM-HIGH trial. Journal of the American College of Cardiology, 2013;62(17):1575-1579
- Martens CR et al. Chronic nicotinamide riboside supplementation is well-tolerated and elevates NAD+ in healthy middle-aged and older adults. Nature Communications, 2018;9:1286
Educational context only, not medical advice or a diagnosis. Always discuss your results with a clinician.








